Target intelligence / Profile preview

MT-CO3 pseudogene 16 (MTCO3P16)

Target
MTCO3P16
Molecular classification
Other (pseudogene)
01

Overview

MT-CO3 pseudogene 16 (MTCO3P16) is annotated as a pseudogene, meaning it is a non-functional genomic sequence related to the gene encoding cytochrome c oxidase subunit III[3]. Pseudogenes are typically regarded as molecular fossils, with no protein product and no established function as a receptor, enzyme, or drug target. MTCO3P16 is not considered a therapeutic target, does not encode a protein, and lacks associations with disease or drug response. Its alternative name, "ALS2CR3," and its relationship to mitochondrial genes may cause confusion, but the functional gene is MT-CO3, not MTCO3P16[3].\n\nNote: MTCO3P16 is correctly classified as a pseudogene, not a receptor, enzyme, or genuine therapeutic target. Any query or annotation treating it as a functional target would be incorrect[3]. The relevant, functional protein-coding gene is *MT-CO3* (cytochrome c oxidase subunit III), not this pseudogene[1][2][5][7].

Other names
MTCO3P16ALS2CR3mitochondrially encoded cytochrome c oxidase III pseudogene 16
02

Mechanism of action

null (not a target for therapeutic intervention)

03

Biological functions

null (no demonstrated biological function)
04

Disease associations

null (no direct disease association)
05

Safety considerations

null (not used therapeutically or as a biomarker)
06

Interacting drugs

null (no known drug interactions)
07

Biomarkers

null (not described as a biomarker)

Beyond the preview

Go deeper on MT-CO3 pseudogene 16 (MTCO3P16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-CO3 pseudogene 16 (MTCO3P16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call